pancreatic%20cancer
PANCREATIC CANCER
Pancreatic cancer is malignancy arising from the pancreas.
It is the 13th most common cancer in the world, 10th most common in the United States, and 4th leading cause of cancer-related deaths in the United Stated and Europe.
Exocrine tumors account for 95% of malignant pancreatic disease.
It is more common in women.
The median age of occurrence is at 71 years old.

Pancreatic%20cancer Signs and Symptoms

  • 13th most common cancer in the world
  • 10th most common cancer in the US
  • 4th leading cause of cancer-related deaths in the US and 7th in Europe
  • Exocrine tumors account for 95% of malignant pancreatic disease and these are adenocarcinomas
  • 30% more common in men than in women
  • Median age of occurrence: 71 years
  • Most highly fatal cancer: Overall 5-year survival rate is <5%
  • Presentation % of patients at initial diagnosis Median survival rate
    Resectable/borderline resectable 15-20% 20-24 months
    Locally advanced/unresectable 25-30% 8-14 months
    Metastatic disease 50-60% 4-6 months
  • Most common anatomic location: 80% head, 15% body, 5% tail of the pancreas

Signs and Symptoms

  • Jaundice
    • Common in patients with malignancy in the head of the pancreas
  • Abdominal pain
    • Common in patients with tumors located in the body and tail of the pancreas
  • Weight loss
  • Back pain
  • Symptoms secondary to compression caused by the tumor:
    • Nausea/vomiting
    • Anorexia
    • Dyspepsia
    • Gastrointestinal bleeding
  • Symptoms caused by biliary obstruction:
    • Dark urine
    • Lightly colored-grayish stool
    • Pruritus
    • Infections (cholangitis, pancreatitis)
    • Scleral icterus
  • Symptoms caused by pancreatic enzyme insufficiency:
    • Malabsorption
    • Fatty stools
    • Increased flatulence
    • Ascites

Risk Factors

High Risk
  • Familial atypical multiple mole melanoma (FAMMM)
  • Hereditary pancreatitis
  • Peutz-Jeghers syndrome
  • >3 1st-degree relatives diagnosed w/ pancreatic cancer
Moderate Risk
  • 2 1st-degree relatives diagnosed w/ pancreatic cancer
  • Cystic fibrosis
  • Chronic pancreatitis
  • BRCA2 mutation carrier
  • PALB2 mutation carrier
Low Risk
  • Cigarette smoking
  • Diabetes mellitus (DM)
  • Obesity/increased body mass index (BMI)
  • Occupational exposure to chemicals (eg beta-naphthylamine, benzidine)
  • Heavy alcohol consumption
  • One 1st-degree relative diagnosed w/ pancreatic cancer
  • Increased consumption of red/processed meat and dairy products
  • Low intake of fruits & vegetables
  • Low plasma 25-hydroxyvitamin D levels
  • History of gallstones & H. pylori infection
  • BRCA1 mutation carrier
  • Familial adenomatous polyposis
  • Li-Fraumeni syndrome
  • Lynch syndrome
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.